STAT: Morning Rounds | Sponsored by Paraxel |  13 August 2018

Other talking points from the news

FDA approves landmark drug and controversial app
Monsanto ordered to pay $289 million in Roundup cancer ruling
SPONSOR CONTENT BY PAREXEL | Drug development is too slow and too costly. Four key innovations could help…but they must be widely adopted… Read More STAT: Morning Rounds | Sponsored by Paraxel |  13 August 2018

BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up

Top Marketing News

How molecular biomarkers are transforming cancer treatment

AbbVie goes 3-0 in delaying Humira rivals

Drug lobby aims to shake up how medicines are paid for

Where does J&J’s new drug fit in the crowded HIV market?
5 drugs to watch as biotechs report Q2

FDA seeks to make more drugs available over the counter

Gilenya patent decision gives MS market a reprieve… Read More BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up